Top Tech Companies (2,068)
Don't see your company?
Create a company profile
Arc Machines, Inc. (AMI), designs, manufactures and distributes state-of-the-art and highly sophisticated automated orbital welding equipment for the power generation, oil & gas, semiconductor, aerospace, high purity, and other industries. Founded in 1976, AMI is headquartered in Pacoima, CA with offices in Houston, TX, Switzerland, Germany, UK, and India. An expansive network of domestic and international representatives allows AMI to sell and support equipment around the world. AMI offers complete products and welding solutions for: Aerospace Nuclear Heat Engineering Manufacturing Vessel Manufacturing Power Generation Semiconductor Shipbuilding Vessel Manufacturing Wastewater Treatment Offshore Petrochemical Fossil Pharmaceutical/Biotechnology/Medical Pulp/Paper Food/Dairy/Beverage One-of-a-kind Industries AMI is not only a leader in designing and manufacturing orbital welding equipment but is also a global solutions provider for all welding-related automation. Recognizing the demand increase for zero defects welding and the rapidly expanding sophistication and complexity of automated welding applications, AMI is dedicated to supporting every aspect of automated welding, machining, robotics, and process development. AMI offers comprehensive and innovative design, implementation, and support to take your next project from concept to completion!
Mendel is the technology platform hub for Koch Biological Solutions, a global leader in delivering targeted, science-based biological products to improve crop productivity. In 2019, KBIO became part of Plant Response, Inc.
Entoura is building an institutional scale & high quality and supply chain solution for Hemp, CBD Oil and Isolates. We have developed a multidisciplinary approach, bringing the best of genetic research, innovative farm practices, whole plant processing techniques, and manufacturing to produce the highest quality hemp derived cannabinoid products in a controlled supply chain environment, ensuring every stage, from seed to sale, maintains the highest standards of consistency, safety, sustainability, and product purity.
HUYABIO is the leader in accelerating the global development of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective and lower-risk drug development in the global markets. Through extensive collaboration with biopharmaceutical, academic and commercial organizations, it has built the largest China-sourced compound portfolio covering all therapeutic areas. With offices in the US, Japan, South Korea, Canada, Ireland and eight strategic locations across China, the Company has become a partner of choice to accelerate product development and maximize value globally.
Readout is a sensor biomarker startup that enables sustained metabolic optimization of patients and self-care consumers with fat oxidation biofeedback in breath. We introduced Biosense in 2020 as a Class 1 medical device for in-home behavior modification. Our digital experience allows "dosing" of ketosis with a patented deep lung sampling technology in a precision nutrition journey from weight loss to healthspan in the palm of your hands.
Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance.
As much as 99% of bacteria in the natural world can’t be seen with the human eye and are unknown. Uncovering the secrets of microbes & biodiversity should be the scientific quest for our era. BiOWiSH® provides industry-leading biotechnology solutions for the agriculture and environmental management industries. Our product range is proven to deliver consistent performance globally for agricultural applications, aquaculture production, and the water treatment industry. Led by former P&G scientists and senior executives based in Cincinnati, Ohio, the company has formed partnerships with leading research institutions around the world, to explore and develop a wide range of commercial applications for its proprietary technology. BiOWiSH Technologies was formed to commercialize composite biocatalysts and probiotics derived from a unique blend of naturally occurring microorganisms, enzymes, and co-factors. These materials enhance the rate and efficiency of biochemical systems over a wide range of environmental conditions.
Genialis is a computational precision medicines company unravelling complex biology to find new ways to address disease. ResponderID™, Genialis’ clinical biomarker discovery platform, defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical development. Genialis is trusted by biopharma and big pharma alike, and together, we bring precision to medicine.
We cultivate authentic materials without compromise,by harnessing science and nature responsibly by partnering the most innovative minds in science and technology with the finest craftspeople to accelerate the use of cellular agriculture for good. Our first product is slaughter-free, real leather.
Through innovation in measurement and automation, we make your bio-process excellent. California-based Finesse Solutions brings Silicon Valley Technology to Bio-processing. - Better performance, integrated intelligence, and plug-and-play bio-process flexibility are provided by Finesse SmartParts™. - Our TruFluor® single-use sensors are unparalleled in the industry. - Our G3 Universal™ controllers enable sophisticated cell culture or fermentation recipes to run on any size or brand of vessel. - Our TruBio® software provides an easy-to-use interface for upstream bio-processing that can harmonize old and new equipment, aggregate in-line and off-line data, and electronically facilitate global technology transfer. - Finesse enables you to supercharge your R&D laboratory or scale-up to a cGMP SmartFactory with equal ease: we offer complete services, including commissioning and validation. We are the people for bio-process management.
Hygiena delivers rapid microbial detection, monitoring, and identification solutions to a wide range of industries, including food and beverage, healthcare, hospitality, pharmaceuticals, and personal care. Utilizing advanced technologies and patented designs, Hygiena provides industry-leading ATP monitoring systems, PCR-based pathogen detection and characterization systems, allergen tests, environmental collection devices, and more. Hygiena is committed to the mission of providing customers with high-quality innovative technologies that are easy-to-use and reliable, backed by excellent customer service and support. Headquartered in Camarillo, California with multiple offices around the world including Wilmington, Delaware, United Kingdom, Spain, Canada, Mexico, South Africa, and China, and over 180 distributors in more than 100 countries worldwide, Hygiena products span the globe.
Welcome to the new era of skin cancer detection. At DermTech we bring precision to the practice of dermatology through non-invasive genomic testing. And we developed the Smart Sticker™ that's making it possible. The DermTech Smart Sticker collects an RNA sample by painlessly lifting skin cells off the entire surface of a mole. This gives doctors the power to diagnose skin cancer in its earliest stages—without a scalpel, without cutting, without scarring. After collection, stickers are sent to our team of scientists in the Gene Lab, the only commercial lab to extract nucleic acids and other proteins from non-invasive skin samples. We amplify RNA molecules to detect two specific genes that are highly predictive of melanoma—PRAME and LINC00518. This process provides 10,000x greater precision in the ability to detect melanoma. We have created the step before the scalpel—a tool doctors have never had before. Now the doctor has the choice of using a non-invasive, highly accurate test to check for melanoma without cutting. And this is just the beginning. We are developing other tests using the Smart Sticker that will further advance early disease detection. Help us change the world of dermatology. Together let’s diagnose skin cancer early and make melanoma a disease of the past.
Founded in 1995, Meso Scale Discovery (MSD) is a global leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological samples. MSD’s proprietary MULTI ARRAY technology enhances medical research and drug development by enabling researchers to profile many biomarkers simultaneously in a single sample without compromising assay performance. MSD’s technology has been widely adopted by researchers in pharmaceutical companies, government institutions, universities, and clinical laboratories worldwide for its high sensitivity, excellent reproducibility, and wide dynamic range. Throughout its history, MSD has continued to evolve its technology platform to enable researchers to solve complex biological questions and, as the Company looks toward the future, it is expanding into clinical applications and the emerging fields of personalized medicine and companion diagnostics.
Navigate BioPharma Services, Inc.,* delivers high quality, innovative and differentiated solutions for drug development and diagnostic applications. As a trusted partner, we support custom assay development and end-to-end clinical trial testing from sample logistics to project and data management for global clinical trials. Our broad portfolio of diverse technologies for clinical biomarker and diagnostic applications are run by specialized professionals experienced in GxP, CAP and CLIA requirements. *Navigate BioPharma is an independent subsidiary of Novartis.
Southern Research is a nonprofit, translational scientific research organization with an 80-year legacy of moving science through drug discovery, drug development and environmental health. This legacy includes helping shape modern cancer treatment practices by developing seven FDA-approved cancer drugs and co-creating a COVID-19 vaccine currently in clinical trials. These innovations are made possible because of our greatest assets, our people that move science every day at every level of Southern Research.
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its nVista and nVoke products, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia. Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors. To learn more about Inscopix visit: www.inscopix.com
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types. Our approach has the potential to precisely direct different immune mediators against a range of target immune cell-types and create best-in-class immunotherapies in cancer, autoimmune and infectious diseases. Asher Bio is backed by Third Rock Ventures and is located in South San Francisco.
64x Bio is transforming the future of cell and gene therapy manufacturing with high throughput discovery and design of enhanced cell lines for next-generation biomanufacturing and therapeutics
Brii Biosciences (Brii Bio) is a company committed to serving patients’ needs and improving public health in China. Founded in early 2018, the company focuses on accelerating innovation and optimizing access to the latest medicines for Chinese patients. Brii Bio helps global partners drive growth and improve return on investment through better understanding of Chinese healthcare systems and access to the world’s second largest pharmaceutical market. The company’s focus is treatments for chronic illnesses with significant burdens, including infectious diseases, liver and lung diseases, and other illnesses. The company is headquartered in the People’s Republic of China and the United States, with offices in Shanghai, Beijing, San Francisco, and Durham, North Carolina.
Mindera Health™ is commercializing scalable extraction technology and data analysis to report a patient’s individual transcriptomic data. Mindera’s technology creates Dermal Intelligence™, actionable information for payers, providers and patients. The company’s flagship test, Mind.Px, uses both a dermal biomarker patch and Machine Learning to determine a patient’s receptivity to very expensive psoriasis biologics. This information is valuable to payers, who can save thousands of dollars per biologic patient using Mind.Px at the outset of prescription. Mind.Px is the first test in a large planned product pipeline, including psoriatic arthritis and eczema biologic receptivity.
